Lateral Epicondylitis Continuous Radiofrequency Microtenotomy

prospective study measuring the outcome of continuous radio frequency 60 degree on lateral epicondylitis not responding to traditional ultrasound guided injection

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Tennis Elbow Arm Injuries Elbow Injuries Elbow Tendinopathy Muscular Diseases Musculoskeletal Diseases Tendinopathy Tendon Injuries Wounds and Injuries

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Baghdad Medical City

Baghdad, 10001, Iraq

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

chronic tennis elbow no response to traditional injection ultrasound exam reveal swelling of common extensor tendon

Exclusion criteria

complete tear of common extensor tendon implanted pace maker

Treatment and study plan

60 degree thermal radiofequency of tennis elbow

Procedure

under strict aseptic technique ultrasound guided TRF of lateral epicondylitis advanced for 5 mm active tip canula

Primary outcomes

decrease in pain score after CRF

Time frame: 6 months

decrease in numerical analogue score

Sponsors and collaborators

Lead sponsor

Iraqi Board of medical specialties

Other

Registry information

Official study title

Efficacy of Continuous Radiofrequency 60 Celsius Degree in Management of Chronic Lateral Epicondylitis Prospective Study

Important dates

Study start: 2023
Primary completion: 2024
Study completion: 2024
First posted: Nov 3, 2023
Registry last updated: Oct 15, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed